Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions (SPORTS)
Sponsor: B. Braun Melsungen AG
Listed as NCT03332264, this NA trial focuses on Occlusion and Restenosis and remains completed. Sponsored by B. Braun Melsungen AG, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2022 — Mar 2024 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jul 2022 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Dec 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- B. Braun Melsungen AG
- Boston Scientific Corporation
- InnoRa GmbH
For direct contact, visit the study record on ClinicalTrials.gov .